ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,082Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 783

$857K Total Retail Price of All Prescriptions

Rank: 75 out of 783

497 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,427 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 613 524 1 4
AMLODIPINE BESYLATE 500 437 2 5
PRAVASTATIN SODIUM 415 376 3 14
FUROSEMIDE 403 369 4 7
HYDROCODONE-ACETAMINOPHEN 314 291 S3 5 2
GABAPENTIN 308 266 6 15
ATORVASTATIN CALCIUM 278 248 7 11
LEVOTHYROXINE SODIUM 260 224 8 1
SIMVASTATIN 237 226 9 3
ATENOLOL 225 180 10 17
OMEPRAZOLE 214 176 11 6
CRESTOR 207 157 12 27
CITALOPRAM HBR 203 180 13 19
ALLOPURINOL 202 177 14 31
METFORMIN HCL 192 161 15 8
GLIMEPIRIDE 174 156 16 34
FAMOTIDINE 174 159 16 55
CEPHALEXIN 172 164 18 70
SPIRONOLACTONE 168 156 19 57
WARFARIN SODIUM 168 120 19 10
LOSARTAN POTASSIUM 165 149 21 18
DONEPEZIL HCL 153 153 22 24
CARVEDILOL 152 128 23 21
DOXAZOSIN MESYLATE 152 144 23 87
TAMSULOSIN HCL 141 110 25 26
NOVOLIN 70-30 140 115 26 227
PREDNISONE 131 119 27 36
NAMENDA 123 123 28 32
METOPROLOL SUCCINATE 113 103 29 13
METOPROLOL TARTRATE 108 101 30 9
POLYETHYLENE GLYCOL 3350 104 102 31 43
KLOR-CON M20 102 93 32 48
HUMULIN 70-30 101 89 33 211
ZETIA 93 71 34 80
TRAMADOL HCL 90 83 35 20
ACTOS 86 79 36 149
INSULIN SYRINGE 86 66 36 82
TRIAMTERENE-HYDROCHLOROTHIAZID 85 70 38 173
NOVOLOG MIX 70-30 FLEXPEN 79 44 39 350
AMITRIPTYLINE HCL 77 56 R 40 77
RANITIDINE HCL 75 69 41 44
ALENDRONATE SODIUM 73 73 42 25
DIOVAN 73 61 42 49
CLOPIDOGREL 70 70 44 29
ESCITALOPRAM OXALATE 70 51 44 54
BACLOFEN 66 30 46 125
POTASSIUM CHLORIDE 62 48 47 16
JANUVIA 61 60 48 73
NEXIUM 58 52 49 28
OLANZAPINE 58 58 49 108
WELCHOL 56 56 51 234
SERTRALINE HCL 56 54 51 22
PEN NEEDLE 56 43 51 103
HYDRALAZINE HCL 51 35 54 78
HYDROCHLOROTHIAZIDE 50 42 55 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.